‘Michael’ Made More Than Enough Money to Warrant a Sequel, but a Biopic Sequel Is Almost Unprecedented

Why It Matters

The box‑office success proves strong audience appetite for Jackson’s story, making a sequel a potentially lucrative venture. However, legal constraints and the rarity of biopic sequels create strategic and creative challenges for Lionsgate.

Key Takeaways

• Michael biopic earned $218.7 million worldwide, record for genre
• Domestic opening $97 million, surpassing previous music biopic benchmarks
• Critics gave 38% Rotten Tomatoes, audiences 97%
• 30% of original footage unused, potential sequel material
• Legal settlements limit depiction of abuse allegations in sequel

Pulse Analysis

The unprecedented box‑office performance of "Michael" signals a shift in how music biopics are received. While past titles like "Straight Outta Compton" and "Bohemian Rhapsody" achieved solid returns, none have matched the $218.7 million global haul of Fuqua’s Jackson portrait. This surge reflects a broader trend: audiences are eager for immersive, nostalgia‑driven storytelling that balances spectacle with personal drama. Studios are therefore more willing to gamble on high‑budget biopics, especially when they can leverage a built‑in fan base and cross‑generational appeal.

A sequel, however, faces a unique set of hurdles. The original film’s legal entanglements—most notably settlement clauses that bar depiction of certain abuse allegations—limit narrative options. Moreover, the 30% of unused footage, while a valuable resource, may not provide enough fresh material to justify a full‑length follow‑up without new production costs. Lionsgate must also navigate cast contracts, salary expectations, and the risk of audience fatigue. The stark contrast between a 38% critic score and a 97% audience rating underscores the delicate balance between artistic credibility and fan service, a factor that will shape any sequel’s creative direction.

If Lionsgate proceeds, the sequel could redefine the biopic model by treating the subject’s life as a multi‑part saga, akin to franchise storytelling in superhero cinema. Success would encourage other studios to revisit iconic musicians and cultural figures, potentially spawning a new wave of serialized biographical films. Conversely, a misstep could reinforce the notion that biopic sequels are an outlier, deterring future investments. Either outcome will provide valuable data on audience tolerance for extended real‑life narratives and the commercial viability of expanding a single‑film biography into a franchise.